Stockreport

Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF patients with rare, life-threatening disease, for which there are no approved treatment options in U.S. – CARLSBAD, Calif. March 25, 2024 /PRNewswire/ -- Ionis Pharmac [Read more]